Priya N. Werahera, PhD, presented “MRI-Invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates” during the 34th International Prostate Cancer Update on February 13, 2024, in Vail, Colorado.

This content is available free to the GRU Community. Login or create an account to view it.

Login

Create an Account

How to cite: Werahera, Priya N. “MRI-Invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates.” February 2024. Accessed Aug 2024. https://grandroundsinurology.com/mri-invisible-prostate-cancer-and-use-of-biomarkers-to-identify-potential-candidates/

MRI-Invisible Prostate Cancer and Use of Biomarkers to Identify Potential Candidates – Summary

Priya N. Werahera, PhD, discusses the challenges of MRI-invisible prostate cancer and biomarkers in prostate cancer diagnosis and treatment. His discussion highlights the limitations of current imaging techniques and the approaches being developed to overcome these obstacles.

Dr. Werahera begins by addressing the inherent difficulties in detecting prostate cancer lesions that evade MRI visibility. He emphasizes the role of biomarkers, which can reveal the presence of cancerous changes even when imaging results appear normal, as a complementary tool to imaging techniques.

By combining biomarker analysis with existing imaging techniques, clinicians can achieve a higher diagnostic yield and better tailor treatment strategies to individual patients. Dr. Werahera calls for collaborative efforts to validate and standardize biomarker use, ensuring their reliability and accessibility in routine clinical practice.

 

About The 34th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 34th iteration of the meeting occurred February 11-14, 2024 in Vail, Colorado. To view more educational presentations from IPCU 34, visit our collection page.